CAMBRIDGE, Mass., Jan. 16, 2018 -- Interface People (IPeople), a premiere healthcare integration provider and Novaseek Research, Inc., a health IT for life sciences organization, today announced a partnership to enable easier integration of Novaseek’s Clinical Data Network for Research (CDNR) platform into hospital/clinical IT systems. Through this collaboration, Novaseek’s hospital and lab partners will gain access to on-site installation consultants who will install the CDNR platform without disruption of normal workflow.
“Partnering with Novaseek builds on our ongoing commitment to continually improve the quality and efficiency of experience with clients’ data,” said Jenny Blue, CEO and Partner of IPeople. “IPeople is excited to be able to assist organizations with clinical research by helping streamline the integration between the HCIS system and Novaseek’s powerful CDNR solution.”
“Our partnership with IPeople makes Novaseek’s CDNR platform even easier and simpler to install by removing the implementation burden from the hospital or lab’s IT personnel, freeing them to focus on day-to-day operations,” said Andrei Soran, chief executive officer, Novaseek Research. “By streamlining this process, Novaseek’s hospital and clinical lab partners are able to begin contributing to research and generating revenue with greater ease and speed than ever before.”
About CDNR
Novaseek’s award-winning novel platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources in real time and enables researchers to define patient cohorts through population analytics and to access consented biospecimens and clinical data to advance translational medicine, clinical development and observational studies. Hospitals and clinical laboratories are enabled to participate in clinical research at the community level while generating additional revenue.
About Novaseek
Novaseek Research, Inc. is a game-changing health IT for life sciences company that provides turn-key, dynamic access to real world clinical data and biospecimens from a network of healthcare organizations. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.
About IPeople
As a premiere healthcare integration provider, IPeople combines innovative solutions with in-depth industry knowledge for smarter, easier access to data. IPeople's HCIS expertise takes them to the next level of building reliable and efficient bi-directional interfaces that organizations can trust. For the last 15 years, IPeople has earned a solid reputation for providing robust and reliable interface solutions to the healthcare community. The IPeople team is committed to continually improving the quality and efficiency of your experience with your data. For more information, please visit http://www.ipeople.com.
| Contact(s) Information | |
| Jenny Blue CEO and Partner IPeople [email protected] (214) 222-1125 | Terri Clevenger For Novaseek Research Continuum Health Communications [email protected] (203) 856-4326 |


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



